rs2852618

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_021956.5(GRIK2):​c.2563-5970A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.423 in 149,996 control chromosomes in the GnomAD database, including 13,613 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.42 ( 13613 hom., cov: 31)

Consequence

GRIK2
NM_021956.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.342

Publications

1 publications found
Variant links:
Genes affected
GRIK2 (HGNC:4580): (glutamate ionotropic receptor kainate type subunit 2) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. This gene product belongs to the kainate family of glutamate receptors, which are composed of four subunits and function as ligand-activated ion channels. The subunit encoded by this gene is subject to RNA editing at multiple sites within the first and second transmembrane domains, which is thought to alter the structure and function of the receptor complex. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. Mutations in this gene have been associated with autosomal recessive cognitive disability. [provided by RefSeq, Jul 2008]
GRIK2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, MODERATE Submitted by: ClinGen
  • intellectual disability, autosomal recessive 6
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • neurodevelopmental disorder with impaired language and ataxia and with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • autosomal recessive non-syndromic intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.466 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021956.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIK2
NM_021956.5
MANE Select
c.2563-5970A>G
intron
N/ANP_068775.1
GRIK2
NM_001166247.1
c.2563-3420A>G
intron
N/ANP_001159719.1
GRIK2
NM_175768.3
c.2563-1585A>G
intron
N/ANP_786944.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIK2
ENST00000369134.9
TSL:5 MANE Select
c.2563-5970A>G
intron
N/AENSP00000358130.6
GRIK2
ENST00000421544.6
TSL:1
c.2563-5970A>G
intron
N/AENSP00000397026.1
GRIK2
ENST00000369138.5
TSL:1
c.2563-3420A>G
intron
N/AENSP00000358134.1

Frequencies

GnomAD3 genomes
AF:
0.423
AC:
63407
AN:
149878
Hom.:
13614
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.356
Gnomad AMI
AF:
0.625
Gnomad AMR
AF:
0.438
Gnomad ASJ
AF:
0.434
Gnomad EAS
AF:
0.351
Gnomad SAS
AF:
0.309
Gnomad FIN
AF:
0.426
Gnomad MID
AF:
0.465
Gnomad NFE
AF:
0.470
Gnomad OTH
AF:
0.435
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.423
AC:
63429
AN:
149996
Hom.:
13613
Cov.:
31
AF XY:
0.417
AC XY:
30599
AN XY:
73298
show subpopulations
African (AFR)
AF:
0.356
AC:
14703
AN:
41274
American (AMR)
AF:
0.438
AC:
6563
AN:
14992
Ashkenazi Jewish (ASJ)
AF:
0.434
AC:
1489
AN:
3434
East Asian (EAS)
AF:
0.351
AC:
1794
AN:
5116
South Asian (SAS)
AF:
0.310
AC:
1490
AN:
4812
European-Finnish (FIN)
AF:
0.426
AC:
4475
AN:
10502
Middle Eastern (MID)
AF:
0.483
AC:
141
AN:
292
European-Non Finnish (NFE)
AF:
0.470
AC:
31309
AN:
66584
Other (OTH)
AF:
0.431
AC:
896
AN:
2080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1838
3675
5513
7350
9188
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
592
1184
1776
2368
2960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.447
Hom.:
2476
Bravo
AF:
0.426
Asia WGS
AF:
0.312
AC:
1080
AN:
3458

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
3.5
DANN
Benign
0.75
PhyloP100
-0.34
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2852618; hg19: chr6-102510252; COSMIC: COSV59767275; API